|

Gonadotropin-releasing Hormone Analog Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: GnRH Agonist, GnRH Analog, Gonadotropin-Releasing Hormone Agonist, Gonadotropin-Releasing Hormone Analogue, LH-RH Analogs +4 more

Pipeline

Phase 2: 2

Top Sponsors

  • University of Washington1
  • Mayo Clinic1

Indications

  • Cancer2
  • Locally Advanced Unresectable Hormone Receptor-Positive Breast Carcinoma1
  • Locally Advanced Unresectable HER2-Negative Breast Carcinoma1
  • Metastatic Hormone Receptor-Positive Breast Carcinoma1
  • Metastatic HER2 Negative Breast Carcinoma1

Scottsdale, Arizona1 trial

Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer

Mayo Clinic in Arizona

Phase 2

St Louis, Missouri1 trial

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

Siteman Cancer Center at Washington University

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.